Skip to main content
DNA Labs India

LIAS Gene Pyruvate dehydrogenase lipoic acid synthetase deficiency NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

LIAS Gene Pyruvate dehydrogenase lipoic acid synthetase deficiency NGS Genetic Test

Short Name: LIAS Gene NGS Test

Also known as: LIAS Deficiency Genetic Test, Lipoic Acid Synthetase Gene Sequencing, LIAS NGS Panel, PDH Lipoic Acid Synthetase Gene Test, LIAS Mutation Analysis

LIAS Gene Pyruvate dehydrogenase lipoic acid synthetase deficiency NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger Confirmation, Bioinformatics Analysis on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be prioritized upon request.. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)All Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify mutations in the LIAS gene that cause pyruvate dehydrogenase lipoic acid synthetase deficiency. It is used to confirm clinical suspicion of the disorder, guide management decisions, enable accurate genetic counseling, and facilitate carrier testing and prenatal or preimplantation genetic diagnosis for at-risk families.

Test Code
2229
CPT Code
81404
ICD Code
E88.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be prioritized upon request.
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger Confirmation, Bioinformatics Analysis
Step 1

Sample Collection

No special preparation such as fasting is required. Ensure that a Genetic Counselling session is completed prior to sample collection to draw a detailed pedigree chart of family members affected with or suspected to have pyruvate dehydrogenase lipoic acid synthetase deficiency. Provide complete clinical history of the patient, including prior metabolic workup results, imaging studies, and family history.

Method: Venipuncture / FTA Card finger-prick

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of venous blood in an EDTA vacutainer, or a single drop of blood can be applied to an FTA card. The sample is labeled accurately and sealed for transport under ambient room temperature conditions.

Step 3

Report Delivery

The sample is transported to the DNA Labs India molecular genetics laboratory under controlled conditions. DNA extraction is performed, followed by NGS library preparation, sequencing, and bioinformatics analysis. A comprehensive report with variant interpretation is generated and reviewed by a clinical geneticist.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be prioritized upon request.

Patient Instructions

1
Before the Test:No fasting or special dietary preparation is required. A pre-test Genetic Counselling session is mandatory to collect detailed family history, draw a pedigree chart, discuss implications of testing, and obtain informed consent. Provide all available clinical records including prior metabolic and biochemical test results.
2
During the Test:Sample collection involves a simple venipuncture to draw 3-5 mL of blood in an EDTA tube or a finger-prick blood spot on an FTA card. The procedure takes approximately 5-10 minutes. Free home collection is available across India for online bookings.
3
After the Test:After sample collection, the blood sample is transported to the DNA Labs India molecular genetics laboratory. DNA extraction, NGS library preparation, sequencing, data analysis, and variant interpretation are performed. The report is reviewed by a clinical geneticist and made available within 3 to 4 weeks via online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

The purpose of this test is to identify mutations in the LIAS gene that cause pyruvate dehydrogenase lipoic acid synthetase deficiency. It is used to confirm clinical suspicion of the disorder, guide management decisions, enable accurate genetic counseling, and facilitate carrier testing and prenatal or preimplantation genetic diagnosis for at-risk families.

How to Prepare

  • Collect 3-5 mL peripheral venous blood in EDTA (purple top) vacutainer or apply one drop of blood to an FTA card
  • Label the sample tube clearly with patient name, date of birth, and unique sample ID
  • Store at ambient room temperature; do not freeze or expose to excessive heat
  • Transport to the laboratory within 48 hours of collection
  • Include completed test requisition form and informed consent document with the sample
  • Ensure Genetic Counselling session documentation accompanies the sample

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"LIAS gene deficiency is a rare autosomal recessive metabolic disorder. Early molecular diagnosis through NGS is critical for initiating supportive therapy and enabling informed family planning decisions. Prenatal and carrier testing options should be discussed with families during genetic counseling sessions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL whole blood
ContainerEDTA (Purple Top) Vacutainer or FTA Card
Collection MethodVenipuncture / FTA Card finger-prick

Sample Stability

Whole Blood (EDTA)
Extracted DNA
FTA Card
Sample Rejection Criteria:
  • Sample collected in heparin (green top) tube, as heparin inhibits PCR and NGS library preparation
  • Hemolyzed, clotted, or insufficient volume samples
  • Incorrectly labeled or unlabeled samples
  • Samples received without completed requisition form or consent
  • Contaminated or leaking sample containers

Understanding Your Results

The results of the LIAS Gene NGS Genetic Test provide detailed information about the presence or absence of mutations in the LIAS gene. Results should be interpreted by a qualified clinical geneticist or metabolic specialist in conjunction with the patient's clinical presentation, family history, and biochemical findings.
📊

Confirms the diagnosis of LIAS gene pyruvate dehydrogenase lipoic acid synthetase deficiency. Two pathogenic mutations detected on both alleles. Genetic counseling and family screening are recommended.

📊

Confirms the diagnosis. Two different pathogenic mutations detected, one on each allele of the LIAS gene. This is consistent with autosomal recessive inheritance.

📊

The individual is a carrier of LIAS deficiency. Carrier testing of parents and genetic counseling are recommended. Carrier individuals are typically unaffected but can pass the mutation to offspring.

📊

A genetic variant was identified that cannot currently be classified as pathogenic or benign. Clinical correlation, family studies, and functional data may be needed. Re-analysis may be performed as new evidence becomes available.

📊

No disease-causing mutations in the LIAS gene were identified. This result does not completely exclude LIAS deficiency if clinical suspicion is high, as some variants may be outside the detection range. Consider additional metabolic and molecular testing.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or metabolic specialist if your child exhibits unexplained lactic acidosis, developmental delays, seizures, poor feeding, failure to thrive, hypotonia, or respiratory difficulties. If a family member has been diagnosed with LIAS gene deficiency, genetic counseling is recommended for carrier assessment and family planning. Consult your doctor immediately if newborn screening results suggest a metabolic disorder.

Limitations

  • This test does not detect large structural rearrangements beyond the detection capability of the NGS platform unless specifically analyzed
  • Variants of Uncertain Significance (VUS) may be identified that cannot be definitively classified at the time of reporting
  • Deep intronic variants and regulatory region mutations outside the targeted region may not be detected
  • This test does not assess mitochondrial DNA mutations or mutations in other genes involved in the pyruvate dehydrogenase complex
  • Results should always be interpreted in the context of clinical findings and family history by a qualified geneticist

Risks & Considerations

  • Minimal risk associated with blood draw, including minor bruising, discomfort, or rare infection at the puncture site
  • Psychological impact of receiving a genetic diagnosis for a serious metabolic disorder
  • Potential identification of variants of uncertain significance that may cause anxiety
  • Implications for family members who may need carrier testing or genetic counseling

Interfering Factors

  • Degraded or insufficient DNA quality in the sample
  • Recent blood transfusion within the past 4 weeks may affect results
  • Contamination of the sample during collection or transport
  • Presence of mosaicism at low levels may not be detected by standard NGS coverage

Compare With Similar Tests

TestLIAS Gene Pyruvate dehydrogenase lipoic acid synthetase deficiency NGS Genetic TestSanger Sequencing of LIAS GeneBiochemical Testing (Lactate/Pyruvate Levels)Whole Exome Sequencing (WES)Mitochondrial DNA Sequencing
ComparisonLIAS Gene Pyruvate dehydrogenase lipoic acid synthetase deficiency NGS Genetic TestSanger sequencing examines one exon at a time and is less cost-effective for full gene analysis. NGS provides comprehensive coverage of the entire coding region simultaneously with higher throughput and sensitivity for variant detection.Biochemical tests such as blood lactate and pyruvate levels can suggest a metabolic disorder but cannot identify the specific genetic cause. NGS genetic testing provides a definitive molecular diagnosis.WES analyzes all coding regions across the entire genome and may be considered when targeted gene panels are inconclusive. The LIAS-specific NGS test is more focused and cost-effective when clinical suspicion is high for this particular gene.Mitochondrial DNA sequencing detects mutations in mitochondrial genes only. LIAS is a nuclear gene, so nuclear gene NGS testing is required. Both tests may be ordered as part of a comprehensive mitochondrial disorder workup.

Frequently Asked Questions

What is the LIAS Gene Pyruvate Dehydrogenase Lipoic Acid Synthetase Deficiency NGS Genetic Test?
This is a Next Generation Sequencing (NGS) based genetic test that analyzes the LIAS gene for mutations that cause lipoic acid synthetase deficiency, a rare metabolic disorder affecting mitochondrial energy production. The test provides comprehensive sequencing of the entire coding region of the LIAS gene.
Who should undergo this genetic test?
This test is recommended for individuals, particularly infants and children, who present with symptoms such as unexplained lactic acidosis, developmental delay, seizures, hypotonia, poor feeding, failure to thrive, or respiratory difficulties suggestive of a mitochondrial energy metabolism disorder. It is also indicated for carrier testing in families with a known history of LIAS deficiency.
What is the cost of the LIAS Gene NGS Genetic Test in India?
The cost of the LIAS Gene Pyruvate Dehydrogenase Lipoic Acid Synthetase Deficiency NGS Genetic Test at DNA Labs India is INR 20000. This price includes home sample collection, NGS sequencing, bioinformatics analysis, and report delivery.
What sample type is required for this test?
The test can be performed using 3-5 mL of peripheral venous blood collected in an EDTA (purple top) vacutainer, extracted DNA, or one drop of blood applied to an FTA card. No fasting is required prior to sample collection.
How long does it take to receive the test results?
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, or WhatsApp for patient convenience.
How accurate is NGS testing for detecting LIAS gene mutations?
Next Generation Sequencing is a highly accurate and sensitive method for detecting mutations in the LIAS gene, including single nucleotide variants, small insertions, and deletions. It provides comprehensive coverage of the target gene with high depth of sequencing, enabling detection of even rare variants.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings across India. Trained phlebotomists will visit your home to collect the blood sample. This service is available in major cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, and many more locations nationwide.
What does it mean if a Variant of Uncertain Significance (VUS) is found?
A VUS is a genetic variant that has been identified but cannot currently be classified as definitively pathogenic or benign based on available scientific evidence. Additional family studies, functional analysis, and clinical correlation may be needed. VUS results may be reclassified as new research data becomes available.
Is LIAS gene deficiency inherited?
Yes, LIAS gene pyruvate dehydrogenase lipoic acid synthetase deficiency is inherited in an autosomal recessive pattern. This means that both copies of the LIAS gene must carry mutations for the disease to manifest. Parents of an affected child are typically carriers with one mutated copy and are usually unaffected.
Can this test be used for prenatal diagnosis?
Yes, once pathogenic mutations have been identified in a family through this NGS test, prenatal genetic diagnosis or preimplantation genetic testing (PGT) can be offered for subsequent pregnancies. This should be discussed with a clinical geneticist or genetic counselor during the pre-test counseling session.
What is the difference between this test and Whole Exome Sequencing?
The LIAS Gene NGS test is a targeted test that specifically analyzes the LIAS gene with high depth of coverage, making it more cost-effective and focused when there is strong clinical suspicion for this particular disorder. Whole Exome Sequencing (WES) analyzes all coding genes across the genome and is broader but more expensive, typically reserved for cases where targeted testing is inconclusive.
Does DNA Labs India provide genetic counseling with this test?
Yes, a genetic counseling session is a mandatory pre-test requirement and is included with the testing process. A genetic counselor will help draw a pedigree chart, discuss the implications of testing, explain possible outcomes, and guide informed consent. Post-test counseling is also available to help interpret results and discuss management options.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.